Digest Network Come funziona
Network
/
Società
Ph
Non verificato

PharmaEssentia Corporation

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieOncologiaSalute

28 comunicati stampa

Guarda tutti i comunicati
04/11/2026
Ropeg ottiene le approvazioni per le terapie endocrine in tutta l'Asia e gli Stati Uniti ed evidenzia le lacune nell'accesso ai trattamenti in Europa
Fonte
PharmaEssentia Corporation
Emittente
Business Wire
1.00
0
03/11/2026
Ropeg Secures ET Approvals Across Asia and the U.S., Highlighting Treatment Access Gap in Europe
Fonte
PharmaEssentia Corporation
Emittente
Business Wire
1.00
0
03/11/2026
Ropeg Advances Essential Thrombocythemia Treatment Worldwide as European Patients Await Access
Fonte
PharmaEssentia Corporation
Emittente
Business Wire
1.00
0
03/11/2026
Ropeg Wins ET Approvals Across Major Markets as European Patients Await Expanded Access
Fonte
PharmaEssentia Corporation
Emittente
Business Wire
1.00
0
03/11/2026
PharmaEssentia’s Ropeg Expands Global ET Approvals While Europe Awaits Regulatory Clearance
Fonte
PharmaEssentia Corporation
Emittente
Business Wire
1.00
0
26/10/2026
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Eventi
Industria
PharmaEssentia to Present Early-Stage Pipeline Data at the Society for Immunotherapy of Cancer (SITC) Annual Meeting, Highlighting Immuno-Oncology Approaches for Solid Tumors
Fonte
PharmaEssentia Corporation
Emittente
Business Wire
1.00
0
17/10/2026
Dal Taiwan al mondo intero: PharmaEssentia crea una società biofarmaceutica globale completamente integrata che mette i pazienti al centro
Fonte
PharmaEssentia Corporation
Emittente
Business Wire
1.00
0
16/10/2026
From PV to ET to PMF, PharmaEssentia Has Come A Long Way in Fighting Diseases
Fonte
PharmaEssentia Corporation
Emittente
Business Wire
1.00
0
16/10/2026
From Taiwan to the World: PharmaEssentia Builds a Scientist-Led, Fully Integrated Global Biopharmaceutical Company with Patients at Its Core
Fonte
PharmaEssentia Corporation
Emittente
Business Wire
1.00
0
16/10/2026
From Taiwan to the World: PharmaEssentia Expands Global Reach With New Drug Approvals, Overseas Investments
Fonte
PharmaEssentia Corporation
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0